{
    "title": "Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8360955/Antibody-drug-tech-firm-AbCellera-raises-105-million-works-COVID-19.html",
    "date": "2020-05-27",
    "keywords": [
        "abcellera",
        "drug",
        "hansen",
        "jane",
        "company",
        "coronavirus",
        "disease",
        "computer",
        "sample",
        "development",
        "funding",
        "round",
        "facility",
        "discovery",
        "technology",
        "treatment",
        "wednesday",
        "firm",
        "vision",
        "machine",
        "learning",
        "executive",
        "carl",
        "device",
        "size",
        "credit",
        "card",
        "fee",
        "work",
        "royalty",
        "software",
        "science",
        "year",
        "addition",
        "venture",
        "capital",
        "investor",
        "dcvc",
        "bio",
        "grant",
        "government",
        "month",
        "manufacturing",
        "making",
        "antibody",
        "cancer",
        "immunooncology",
        "pain",
        "lanhee",
        "lee",
        "peter",
        "henderson",
        "tom",
        "brown"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}